menu
    • menu

    Company profile for Remix Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Just as an instrument can be tuned to create an entirely different sound, RNA transcripts can also be tuned in a multitude of ways, extending far beyond simply splicing out non-coding introns. Development of new molecular tools and the advent of next-generation, multi-omic disease datasets has given us better insight into RNA’s vast intricacies and unveiled new, exciting insights into how RNA is processed and dysregulated af...
    Just as an instrument can be tuned to create an entirely different sound, RNA transcripts can also be tuned in a multitude of ways, extending far beyond simply splicing out non-coding introns. Development of new molecular tools and the advent of next-generation, multi-omic disease datasets has given us better insight into RNA’s vast intricacies and unveiled new, exciting insights into how RNA is processed and dysregulated after transcription. By unlocking these tools and controlling RNA processing we can target the drivers of disease at their origin, affording rich therapeutic opportunities.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Remix TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    One Kendall Square, Building 200, Cambridge MA 02139
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.remixtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/remix-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Remix Therapeutics To Present at Guggenheim Health Conference
    Remix Therapeutics To Present at Guggenheim Health Conference

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179174/0/en/Remix-Therapeutics-to-Present-at-Guggenheim-Second-Annual-Healthcare-Innovation-Conference.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Remix Therapeutics Reveals Encouraging Phase 1 Data For REM-422
    Remix Therapeutics Reveals Encouraging Phase 1 Data For REM-422

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172910/0/en/Remix-Therapeutics-Announces-Positive-Preliminary-Data-from-Phase-1-Study-of-REM-422-in-Patients-with-Adenoid-Cystic-Carcinoma-at-the-2025-AACR-NCI-EORTC-International-Conference-o.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    Remix Therapeutics To Unveil REM-422 Ph 1 Data at AACR-NCI-EORTC
    Remix Therapeutics To Unveil REM-422 Ph 1 Data at AACR-NCI-EORTC

    13 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/13/3165712/0/en/Remix-Therapeutics-to-Present-Phase-1-Data-of-REM-422-at-the-2025-AACR-NCI-EORTC-International-Conference-on-Molecular-Targets-and-Cancer-Therapeutics-Conference-in-Late-Breaking-O.html

    GLOBENEWSWIRE
    13 Oct 2025
    Share Share
    Remix Therapeutics Appoints Linda C. Bain to Board of Directors
    Remix Therapeutics Appoints Linda C. Bain to Board of Directors

    15 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/15/3061562/0/en/Remix-Therapeutics-Appoints-Linda-C-Bain-to-Board-of-Directors.html

    GLOBENEWSWIRE
    15 Apr 2025
    Share Share
    Remix Therapeutics to Present at Stifel 2025 Oncology Forum
    Remix Therapeutics to Present at Stifel 2025 Oncology Forum

    31 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/31/3052144/0/en/Remix-Therapeutics-to-Present-at-Stifel-2025-Virtual-Targeted-Oncology-Forum.html

    GLOBENEWSWIRE
    31 Mar 2025
    Share Share
    Remix Therapeutics to Attend Leerink Global Healthcare Conference
    Remix Therapeutics to Attend Leerink Global Healthcare Conference

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3033672/0/en/Remix-Therapeutics-Announces-Participation-in-Leerink-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search